首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1391916

支氣管擴張藥物市場：依藥物類別、給藥途徑、配銷通路及地區

Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月10日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球支氣管擴張藥物市場規模為3.348億美元，2030年將達6.607億美元，2023年至2030年複合年成長率為10.2%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	3.348 億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	10.20%	2030年市場規模預測	6.607 億美元

圖 1. 2023 年支氣管擴張藥物的全球市場佔有率（依地區分類）

支氣管擴張是一種肺部管道（氣道）因損傷而變寬或成袋的疾病。排放肺部黏液變得困難，這可能導致頻繁感染疾病。支氣管擴張的主要症狀是咳嗽，經常產生膿液或黏液。支氣管擴張無法治愈，但可以透過治療來控制。

支氣管擴張藥物對於控制支氣管擴張的症狀和併發症至關重要，支氣管擴張是一種以支氣管擴張為特徵的慢性呼吸道疾病。這些藥物旨在緩解慢性咳嗽、黏液分泌過多和反覆呼吸道感染疾病症狀，同時減緩疾病的進展。支氣管擴張藥物包括支氣管擴張劑、黏液清除藥物、抗生素和發炎藥物。這些藥物的開發為改善患者預後和生活品質開闢了新的可能性。正在進行的支氣管擴張研究正在探索新的治療方法和標靶藥物，為更有效的治療和更好的疾病管理帶來希望。

市場動態：

支氣管擴張症盛行率的增加、治療方案的進步以及對個人化醫療的日益關注預計將在預測期內推動全球支氣管擴張藥物市場的成長。此外，支持性的法規環境和市場參與者活性化的研發活動預計將在預測期內推動市場成長。

例如，2022年2月，生物技術公司Armata Pharmaceuticals, Inc.獲得美國食品藥物管理局（FDA）針對第二個適應症——非囊腫纖維化支氣管擴張症的Optimized Lead，並宣布核准Armata的在臨床實驗（IND）申請開始其候選治療藥物 AP-PA02 的臨床試驗。

本研究的主要特點

該報告對全球支氣管擴張藥物市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球支氣管擴張治療藥物市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
全球支氣管擴張藥物市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球支氣管擴張藥物市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 334.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.20%	2030 Value Projection:	US$ 660.7 Mn

Bronchiectasis is a condition where damage causes the tubes in your lungs (airways) to widen or develop pouches. It makes it hard to clear mucus out of your lungs and can cause frequent infections. Coughing a lot with pus and mucus is the main symptom of bronchiectasis. Bronchiectasis can't be cured but can be managed with treatment.

Bronchiectasis drugs are essential for managing the symptoms and complications of bronchiectasis, a chronic respiratory condition characterized by widening of the bronchial tubes. These drugs aim to alleviate symptoms like chronic cough, excessive mucus production, and recurrent respiratory infections while slowing down disease progression. Bronchiectasis drugs encompass bronchodilators, mucus-clearing agents, antibiotics, and anti-inflammatory medicine. Their development has opened new possibilities for improved patient outcomes and quality of life. Ongoing research in bronchiectasis explores novel therapeutic approaches and targeted medications, offering hope for more effective treatments and better disease management.

Market Dynamics:

The increasing prevalence of bronchiectasis, advancements in treatment options, and increasing focus on personalized medicine are anticipated to drive growth of the global bronchiectasis drugs market over the forecast period. Moreover, a supportive regulatory environment and increased research and developmental activities by market players is expected to drive market growth over the forecast period.

For instance, in February 2022, Armata Pharmaceuticals, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared Armata's Investigational New Drug (IND) application to initiate a clinical trial of its optimized lead therapeutic candidate, AP-PA02, in a second indication, non-cystic fibrosis bronchiectasis.

Key features of the study:

This report provides in-depth analysis of the global bronchiectasis drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchiectasis drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, Sunovion Pharmaceuticals, Chiesi Farmaceutici
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bronchiectasis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchiectasis drugs market

Detailed Segmentation:

Bronchiectasis drugs market, By Drug Class:
- Antibiotics
- Mucolytics
- Bronchodilators
- Anti-inflammatory agents
Bronchiectasis drugs market, By Route of Administration:
- Oral
- Inhalation
- Intravenous
Bronchiectasis drugs market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Bronchiectasis drugs market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Bayer
- GlaxoSmithKline
- Boehringer Ingelheim
- Novartis
- AstraZeneca
- Sunovion Pharmaceuticals
- Chiesi Farmaceutici

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bronchiectasis Drugs, By Drug Class
- Market Bronchiectasis Drugs, By Route of Administration
- Market Bronchiectasis Drugs, By Distribution Channel
- Market Bronchiectasis Drugs, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Bronchiectasis
Increasing Awareness of the Disease
- Restraints
Limited Awareness and Underdiagnoses
Lack of Specific Treatment Guidelines
- Opportunities
Unmet Medical Needs
Emerging Markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bronchiectasis Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bronchiectasis Drugs Market , By Drug Class, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Mucolytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Anti-inflammatory agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Bronchiectasis Drugs Market , By Route of Administration, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Bronchiectasis Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Bronchiectasis Drugs Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
China
Japan
India
South Korea
ASEAN
Australia
Rest of Middle East
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Bayer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

支氣管擴張藥物市場：按藥物類別、給藥途徑和最終用戶分類 - 全球預測 2025-2030

支氣管擴張藥物市場，按藥物類別、給藥途徑、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

FAQ

支氣管擴張藥物市場：依藥物類別、給藥途徑、配銷通路及地區